Abbott Laboratories

104.80-1.15-1.09%Vol 4.18M1Y Perf 25.47%
Sep 22nd, 2020 16:02 DELAYED
BID104.01 ASK105.24
Open105.46 Previous Close105.95
Pre-Market106.55 After-Market104.80
 0.60 0.57%  - -%
Target Price
111.58 
Analyst Rating
Strong Buy 1.44
Potential %
6.47 
Finscreener Ranking
★+     44.70
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
     43.28
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★+     57.14
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
★+     39.96
Market Cap185.55B 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
82.14 
Earnings Date
21st Oct 2020

Today's Price Range

103.56105.52

52W Range

61.61114.19

5 Year PE Ratio Range

12.30277.50

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
-0.85%
1 Month
2.34%
3 Months
14.79%
6 Months
66.83%
1 Year
25.47%
3 Years
99.58%
5 Years
149.78%
10 Years
132.84%

TickerPriceChg.Chg.%
ABT104.80-1.1500-1.09
AAPL111.811.73001.57
GOOG1 465.4634.30002.40
MSFT207.424.88002.41
XOM35.53-0.9000-2.47
WFC23.65-0.3900-1.62
JNJ144.21-0.8900-0.61
FB254.756.60002.66
GE6.25-0.1000-1.57
JPM94.27-1.0400-1.09
Financial StrengthValueIndustryS&P 500US Markets
1.10
1.60
0.37
0.64
6.80
Leverage Ratio 2.20
ProfitabilityValueIndustryS&P 500US Markets
57.50
13.10
23.10
10.50
9.89
RevenueValueIndustryS&P 500US Markets
31.44B
17.76
7.60
10.64
DividendsValueIndustryS&P 500US Markets
1.35
1.44
7.74
6.72
Payout ratio66.00
Earnings HistoryEstimateReportedSurprise %
Q02 20200.430.5732.56
Q01 20200.550.6518.18
Q04 20190.950.950.00
Q03 20190.840.840.00
Q02 20190.800.822.50
Q01 20190.610.633.28
Q04 20180.810.810.00
Q03 20180.740.751.35
Earnings Per EndEstimateRevision %Trend
9/2020 QR0.8915.58Positive
12/2020 QR1.1718.18Positive
12/2020 FY3.2716.37Positive
12/2021 FY3.969.39Positive
Next Report Date21st Oct 2020
Estimated EPS Next Report0.89
Estimates Count9
EPS Growth Next 5 Years %11.00
Volume Overview
Volume4.18M
Shares Outstanding1.77B
Trades Count41.83K
Dollar Volume502.03M
Avg. Volume7.40M
Avg. Weekly Volume4.74M
Avg. Monthly Volume7.01M
Avg. Quarterly Volume5.23M

Abbott Laboratories (NYSE: ABT) stock closed at 104.8 per share at the end of the most recent trading day (a -1.09% change compared to the prior day closing price) with a volume of 4.18M shares and market capitalization of 185.55B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 103000 people. Abbott Laboratories CEO is Miles D. White.

The one-year performance of Abbott Laboratories stock is 25.47%, while year-to-date (YTD) performance is 20.65%. ABT stock has a five-year performance of 149.78%. Its 52-week range is between 61.61 and 114.19, which gives ABT stock a 52-week price range ratio of 82.14%

Abbott Laboratories currently has a PE ratio of 61.80, a price-to-book (PB) ratio of 6.19, a price-to-sale (PS) ratio of 6.02, a price to cashflow ratio of 29.80, a PEG ratio of 2.32, a ROA of 4.53%, a ROC of 7.07% and a ROE of 9.99%. The company’s profit margin is 9.89%, its EBITDA margin is 23.10%, and its revenue ttm is $31.44 Billion , which makes it $17.76 revenue per share.

Of the last four earnings reports from Abbott Laboratories, there were 2 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.89 for the next earnings report. Abbott Laboratories’s next earnings report date is 21st Oct 2020.

The consensus rating of Wall Street analysts for Abbott Laboratories is Strong Buy (1.44), with a target price of $111.58, which is +6.47% compared to the current price. The earnings rating for Abbott Laboratories stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Abbott Laboratories has a dividend yield of 1.35% with a dividend per share of $1.44 and a payout ratio of 66.00%.

Abbott Laboratories has a Neutral technical analysis rating based on Technical Indicators (ADX : 23.32, ATR14 : 2.59, CCI20 : -54.89, Chaikin Money Flow : -0.19, MACD : 1.03, Money Flow Index : 38.62, ROC : 0.61, RSI : 50.78, STOCH (14,3) : 31.78, STOCH RSI : 0.00, UO : 51.94, Williams %R : -68.22), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Abbott Laboratories in the last 12-months were: Andrea F. Wainer (Sold 2 549 shares of value $210 549 ), Andrew H. Lane (Option Excercise at a value of $3 505 313), Andrew H. Lane (Sold 80 000 shares of value $7 360 104 ), Brian B. Yoor (Option Excercise at a value of $23 110 673), Brian B. Yoor (Sold 509 850 shares of value $45 747 208 ), Charles R. Brynelsen (Sold 1 781 shares of value $138 722 ), Christopher J. Scoggins (Sold 1 654 shares of value $136 369 ), Daniel Gesua Sive Salvadori (Option Excercise at a value of $1 996 513), Daniel Gesua Sive Salvadori (Sold 43 478 shares of value $4 829 513 ), Hubert L. Allen (Sold 1 208 shares of value $94 091 ), Jaime Contreras (Option Excercise at a value of $6 192 994), Jaime Contreras (Sold 2 001 shares of value $155 858 ), Jared L. Watkin (Sold 10 009 shares of value $813 500 ), John F. Ginascol (Option Excercise at a value of $5 538 464), John F. Ginascol (Sold 69 806 shares of value $6 579 855 ), John M. Capek (Option Excercise at a value of $2 535 691), John M. Capek (Sold 102 400 shares of value $10 653 603 ), Joseph J. Manning (Option Excercise at a value of $1 440 000), Joseph J. Manning (Sold 37 500 shares of value $3 359 411 ), Lisa D. Earnhardt (Sold 872 shares of value $79 216 ), Mary K. Moreland (Sold 1 419 shares of value $124 632 ), Michael D. Dale (Sold 1 183 shares of value $96 532 ), Michael J. Pederson (Option Excercise at a value of $0), Michael J. Pederson (Sold 23 008 shares of value $2 254 784 ), Phebe N. Novakovic (Option Excercise at a value of $187 353), Phebe N. Novakovic (Sold 1 866 shares of value $188 052 ), Philip P. Boudreau (Sold 10 600 shares of value $869 200 ), Randel W. Woodgrift (Option Excercise at a value of $614 400), Randel W. Woodgrift (Sold 28 644 shares of value $2 412 131 ), Robert E. Funck (Option Excercise at a value of $2 673 276), Robert E. Funck (Sold 2 712 shares of value $211 238 ), Roger M. Bird (Sold 6 956 shares of value $735 804 ), Roxanne S. Austin (Sold 13 688 shares of value $1 366 076 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
12 (75.00 %)
12 (75.00 %)
10 (71.43 %)
Moderate Buy
1 (6.25 %)
1 (6.25 %)
1 (7.14 %)
Hold
3 (18.75 %)
3 (18.75 %)
3 (21.43 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.44
Strong Buy
1.44
Strong Buy
1.50

Abbott Laboratories

Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

CEO: Miles D. White

Teplephone: +1 224 667-6100

Address: 100 Abbott Park Road, Abbott Park 60064-6400, IL, USA

Number of employees: 103 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

67%33%

Bearish Bullish

61%39%

Bearish Bullish

41%59%

Bearish Bullish

62%38%

News

Stocktwits